form8k.htm



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 2, 2012


 
(Exact name of registrant as specified in its charter)


Delaware
0-21121
06-1456680
(State or other jurisdiction of incorporation)
(Commission file number)
(I.R.S. employer identification no.)

One Hamden Center
 
2319 Whitney Ave, Suite 3B, Hamden, CT
06518
(Address of principal executive offices)
(Zip Code)

Registrant's telephone number, including area code: (203) 859-6800

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 



 
 

 

Item 2.02 Results of Operations and Financial Condition.

The following information is being furnished pursuant to Item 2.02 “Results of Operations and Financial Condition” of Form 8-K.  Such information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

On November 5, 2012, TransAct Technologies Incorporated (“TransAct”) issued a press release announcing its financial results for the quarter ended September 30, 2012.  Additionally, the Company also announced that its Board of Directors declared a quarterly dividend on its Common Stock in the amount of $.06 per share payable on or about December 12, 2012 to common shareholders of record at the close of business on November 21, 2012. A copy of the press release is furnished as Exhibit 99.1 to this report.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:

Exhibit
 
Description
99.1
 
Press Release dated November 5, 2012 of TransAct Technologies Incorporated


 
 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
TRANSACT TECHNOLOGIES INCORPORATED
   
By:
    /s/ Steven A. DeMartino
   
Steven A. DeMartino
   
President, Chief Financial Officer, Treasurer and Secretary

Date: November 5, 2012



exhibit991.htm
Exhibit 99.1





TRANSACT TECHNOLOGIES REPORTS THIRD QUARTER 2012 RESULTS AND DECLARES FIRST QUARTERLY DIVIDEND

HAMDEN, CT – November 5, 2012 – TransAct Technologies Incorporated (NASDAQ: TACT), a global leader in market-specific solutions, including printers, terminals, software and other products for transaction-based and other industries, today announced financial results for the three and nine months ended September 30, 2012.  Summary results for the period are as follows:

   
Three months ended September 30,
   
Nine months ended September 30,
 
(in $000s, except EPS)
 
2012
   
2011
   
% change
   
2012
   
2011
   
% change
 
Net Sales
 
$
15,358
   
$
14,111
     
8.8
%
 
$
48,770    
$
52,324      
-6.8
%
                                                 
 As reported (GAAP):                                                
     Operating income
   
43
     
1,125
     
-96.2
%
   
2,732
      6,123     -55.4
%
     Net income
   
23
     
839
      -97.3
%
    1,739       4,106    
-57.6
%
     Diluted earnings per share
 
$
0.00
   
$
0.09
      -100.0
%
 
$
0.19
   
$
0.43
   
-55.8
%
 
Adjusted (non-GAAP) (1):                                                
    Operating income
   
1,079
     
1,125
     
-4.1
%
   
4,239
      6,123     -30.8
%
    Net income
    686      
839
      -18.2
%
    2,704       4,106    
-34.1
%
    Diluted earnings per share
 
$
0.08
   
$
0.09
      -11.1
%
 
$
0.29
   
$
0.43
   
-32.6
%
 
“During the third quarter 2012 we experienced revenue gains in the majority of our markets,” said Bart C. Shuldman, Chairman and Chief Executive Officer of TransAct Technologies.  “Further, our confidence in our future as well as our strong cash flow generation led us for the first time in our company’s history to implement a quarterly dividend program.  Looking ahead, we expect a much stronger fourth quarter of 2012 compared to the third quarter of 2012, aided by initial revenue contributions from our recently launched Food Safety and Nutritional Labeling Terminal, newly launched color oil and gas Printrex printers and consumables, and significant order flow for our lottery printers from GTECH.”

Mr. Shuldman continued, “For the third quarter of 2012, our worldwide casino and gaming sales increased 4% from the prior year period, led by solid international growth in Europe and Asia.  Printrex printer sales for the third quarter of 2012 were $1.2 million, up from $0.5 million in the prior-year period, as the prior-year period included only approximately six weeks of sales from Printrex, which we acquired in August 2011.  Lottery sales from GTECH were up 58% from the prior-year period to $2.5 million due to the timing of orders as we will ship most of our 2012 lottery printers in the second half of 2012.  TransAct Services Group revenue increased 10% compared to the prior-year period, led by strong sales of our new paper testing services and sales of spare parts in the international markets.  Banking and POS printer sales declined 35% compared to the prior-year period on expected lower POS sales due to the substantial completion of the McDonald’s U.S. rollout for its combined beverage, grill and POS system upgrade initiatives.  Lastly, our balance sheet remains solid with $8.6 million in cash and no debt outstanding as of September 30, 2012.”
 
 
 

 
 
2012 Outlook

TransAct expects fourth quarter 2012 revenue of at least $19 million and diluted earnings per share, excluding the AVY Legal Fees, of at least $0.20 due largely to the initial revenue contributions from the new Printrex oil and gas color printers, Food Safety and Nutritional Labeling Terminals as well as a backlog of lottery printer orders from GTECH.

Quarterly Dividend Declared

In September 2012, the Company announced it had implemented a quarterly cash dividend policy.  The Board of Directors of the Company has declared its first quarterly dividend payment of $0.06 per share, which will be payable on December 12, 2012 to shareholders of record at the close of business on November 21, 2012.  On an annualized basis, the quarterly dividend announced today represents an annual yield of 3.2% based on the $7.60 per share closing price of the Company’s stock on November 2, 2012.

The Company anticipates paying a cash dividend in March, June, September and December of each year.  However, future declarations of dividends are subject to Board of Director approval and may be adjusted as business needs or market conditions change.

Third Quarter 2012 Results

Revenue for the third quarter of 2012 was $15.4 million, an increase of 9% compared to $14.1 million in the prior-year period.  Gross margin for the third quarter of 2012 was 37.0%, compared to 37.9% in the prior-year quarter due primarily to a less favorable sales mix.  Operating expenses were $5.6 million, an increase of $1.4 million from the prior-year period, driven mainly by $1.0 million of legal fees and other expenses related to the lawsuit with Avery Dennison Corporation, as well as the full quarter effect of Printrex expenses.  Excluding legal fees, operating expenses increased by $0.4 million, or 9%, compared to the prior-year period.  The Company recorded breakeven GAAP net income and diluted earnings per share in the third quarter of 2012, compared to GAAP net income of $0.8 million, or $0.09 per diluted share, in the prior-year period.  Excluding legal fees, the Company recorded adjusted net income in the third quarter of 2012 of $0.7 million, or $0.08 per diluted share.

Commenting on the financial results, Steven A. DeMartino, President and Chief Financial Officer of TransAct Technologies said, “During the third quarter 2012, we were pleased with our overall revenue growth, especially during these uncertain times.  In addition, we successfully launched three new products which will start to add to our revenue in the fourth quarter of 2012 while also completing the final integration of Printrex into TransAct’s operations.  With the integration completed, we expect to see cost savings of approximately $0.2 million per quarter beginning in the fourth quarter of 2012.”

Nine Month 2012 Results

Revenue for the nine months ended September 30, 2012 was $48.8 million, a decrease of 7% compared to $52.3 million in the prior-year period.  Gross margin for the nine months ended September 30, 2012 was 37.5%, an increase of approximately 130 basis points from 36.2% in the prior-year period due primarily to a favorable sales mix.  Operating expenses were $15.6 million, an increase of $2.7 million from the prior-year period, driven mainly by ongoing expenses related to Printrex operations and $1.5 million of legal fees and other expenses related to the lawsuit with Avery Dennison Corporation.  The Company recorded GAAP net income of approximately $1.7 million, or $0.19 per diluted share, for the nine months ended September 30, 2012, compared to GAAP net income of approximately $4.1 million, or $0.43 per diluted share, for the prior-year period.  Excluding legal fees, the Company recorded adjusted net income of approximately $2.7 million, or $0.29 per diluted share, for the nine months ended September 30, 2012.
 
 
 

 
Liquidity and Capital Resources

As of September 30, 2012, the Company had approximately $8.6 million in cash and cash equivalents, and no debt obligations outstanding under its $20 million revolving credit facility.  During the third quarter of 2012, TransAct repurchased 54,283 shares for approximately $0.4 million (average price of $7.60 per share).  Year-to-date through September 30, 2012, TransAct has repurchased approximately 671,000 shares, or 7% of the outstanding shares, for approximately $5.6 million.  TransAct’s $15 million repurchase program allows the Company to repurchase up to $6.6 million in additional shares through May 2013.

Financial Presentation

The Company has provided adjusted non-GAAP financial measures because the Company believes that these amounts are helpful to investors and others to more accurately assess the ongoing nature of TransAct's core operations.  The adjusted non-GAAP measures exclude the effect in the three and nine months ended September 30, 2012 of legal fees and other expenses related to the lawsuit with Avery Dennison Corporation.  This item has been excluded from adjusted non-GAAP financial measures as management does not believe that it is representative of underlying trends in the Company's performance. Its exclusion provides investors and others with additional information to more readily assess the Company's operating results. The Company uses the non-GAAP financial measures internally to focus management on the results of the Company's core business. The presentation of this additional non-GAAP information is not considered superior to or a substitute for the financial information prepared in accordance with GAAP.

Investor Conference Call / Webcast Details

TransAct will review detailed third quarter 2012 results during a conference call today at 5:00 PM EST. The conference call-in number is 888-466-4462. A replay of the call will be available from 8:00 PM EST on Monday, November 5 through midnight EST on Monday, November 12 by telephone at 877-870-5176; passcode 5924064.  Investors can also access the conference call via a live webcast on the Company's Web site at http://www.transact-tech.com.  A replay of the call will be archived on that Web site for one week.

About TransAct Technologies Incorporated

TransAct Technologies Incorporated (NASDAQ: TACT) is a leader in developing and manufacturing market-specific solutions, including printers, terminals, software and other products for transaction-based and other industries. These industries include casino, gaming, lottery, banking, kiosk, point-of-sale, food safety, hospitality, oil and gas, and medical and mobile.  Each individual market has distinct, critical requirements for printing and the transaction is not complete until the receipt and/or ticket is produced.  TransAct printers and products are designed from the ground up based on market specific requirements and are sold under the Ithaca®, Epic, EPICENTRAL® and Printrex® product brands.  TransAct distributes its printers through OEMs, value-added resellers, selected distributors, and direct to end-users.  TransAct has over 2.4 million printers installed around the world.  Beyond printers, TransAct is committed to providing world-class printer service, spare parts, accessories and printing supplies required by a growing worldwide installed base of printers.  Through its TransAct Services Group, TransAct provides a complete range of supplies and consumables items used in the printing and scanning activities of customers in the hospitality, banking, retail, food safety, gaming, government and oil and gas exploration markets.  Through its webstore, http://www.transactsupplies.com, and a direct selling team, TransAct addresses the on-line demand for these products.  TransAct is headquartered in Hamden, CT.  For more information, please visit http://www.transact-tech.com or call 203.859.6800.

Forward-Looking Statements:
Certain statements in this press release include forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe” or “continue” or the negative thereof or other similar words. All forward-looking statements involve risks and uncertainties, including, but are not limited to, customer acceptance and market share gains, both domestically and internationally, in the face of substantial competition from competitors that have broader lines of products and greater financial resources; introduction of new products into the marketplace by competitors; successful product development; dependence on significant customers; dependence on significant vendors; dependence on contract manufacturers for the assembly of a large portion of our products in China; the ability to protect intellectual property; the ability to recruit and retain quality employees as the Company grows; dependence on third parties for sales outside the United States, including Australia, New Zealand, Europe, Latin America and Asia; economic and political conditions in the United States, Australia, New Zealand, Europe, Latin America and Asia; marketplace acceptance of new products; risks associated with foreign operations; availability of third-party components at reasonable prices; price wars or other significant pricing pressures affecting the Company's products in the United States or abroad;  risks associated with potential future acquisitions; the outcome of the lawsuit between TransAct and Avery Dennison Corporation; and other risk factors detailed from time to time in TransAct’s reports filed with the Securities and Exchange Commission. Actual results may differ materially from those discussed in, or implied by, the forward-looking statements. The forward-looking statements speak only as of the date of this release and the Company assumes no duty to update them to reflect new, changing or unanticipated events or circumstances.
 
Contact:
TransAct Technologies Incorporated
Steven DeMartino, President and Chief Financial Officer
203-859-6810
 
ICR Inc.
William Schmitt
203-682-8200
 

 
 

 

 
 
TRANSACT TECHNOLOGIES INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
 
 
(In thousands, except per share data)
 
Three months ended
September 30,
 
   
2012
   
2011
 
   
GAAP
Basis
   
Adjustments
   
Pro Forma
Basis
   
GAAP
Basis
 
                         
Net sales
  $ 15,358     $ -     $ 15,358     $ 14,111  
Cost of sales
    9,679       -       9,679       8,761  
Gross profit
    5,679       -       5,679       5,350  
                                 
Operating expenses:
                               
Engineering, design and product
development
    1,087       -       1,087       848  
Selling and marketing
    1,571       -       1,571       1,458  
General and administrative
    1,919       -       1,919       1,919  
Legal fees associated with lawsuit
    1,036       (1,036) a     -       -  
Business consolidation and
restructuring
    23       -       23       -  
      5,636       (1,036)       4,600       4,225  
Operating income
    43       1,036       1,079       1,125  
                                 
Interest and other income (expense):
                               
Interest, net
    3       -       3       7  
Other, net
    (10)       -       (10)       (17)  
      (7)       -       (7)       (10)  
                                 
Income before income taxes
    36       1,036       1,072       1,115  
Income tax provision
    13       373  b     386       276  
Net income
  $ 23     $ 663     $ 686     $ 839  
                                 
Net income per common share:
                               
Basic
  $ 0.00             $ 0.08     $ 0.09  
Diluted
  $ 0.00             $ 0.08     $ 0.09  
                                 
Shares used in per share calculation:
                               
Basic
    8,822               8,822       9,471  
Diluted
    8,911               8,911       9,661  


 
a
Legal and other expenses of $1,036 related to the lawsuit with Avery Dennison Corporation.
 
b
The tax effect on the adjustments was calculated using an effective tax rate of 36.0%.

 
 

 


TRANSACT TECHNOLOGIES INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
 
 
(In thousands, except per share data)
 
Nine months ended
September 30,
 
   
2012
   
2011
 
   
GAAP
Basis
   
Adjustments
   
Pro Forma
Basis
   
GAAP
Basis
 
                         
Net sales
  $ 48,770     $ -     $ 48,770     $ 52,324  
Cost of sales
    30,471       -       30,471       33,379  
Gross profit
    18,299       -       18,299       18,945  
                                 
Operating expenses:
                               
Engineering, design and product
development
    3,252       -       3,252       2,432  
Selling and marketing
    4,846       -       4,846       4,630  
General and administrative
    5,822               5,822       5,576  
Legal fees associated with lawsuit
    1,507       (1,507) c     -       -  
Business consolidation andrestructuring
    140       -       140       184  
      15,567       (1,507)       14,060       12,822  
Operating income
    2,732       1,507       4,239       6,123  
                                 
Interest and other income (expense):
                               
Interest, net
    7       -       7       18  
Other, net
    (21)       -       (21)       -  
      (14)       -       (14)       18  
                                 
Income before income taxes
    2,718       1,507       4,225       6,141  
Income tax provision
    979       542  d     1,521       2,035  
Net income
  $ 1,739     $ 965     $ 2,704     $ 4,106  
                                 
Net income per common share:
                               
Basic
  $ 0.19             $ 0.30     $ 0.44  
Diluted
  $ 0.19             $ 0.29     $ 0.43  
                                 
Shares used in per share calculation:
                               
Basic
    9,110               9,110       9,435  
Diluted
    9,205               9,205       9,651  

 
c
Legal and other expenses of $1,507 related to the lawsuit with Avery Dennison Corporation.
 
d
The tax effect on the adjustments was calculated using an effective tax rate of 36.0%.

SUPPLEMENTAL INFORMATION – SALES BY SALES UNIT:
 
             
   
Three months ended
   
Nine months ended
 
   
September 30,
   
September 30,
 
   
2012
   
2011
   
2012
   
2011
 
Banking and point-of-sale
  $ 1,829     $ 2,818     $ 6,841     $ 8,106  
Casino and gaming
    6,100       5,861       22,623       18,762  
Lottery
    2,454       1,551       5,212       14,066  
Printrex
    1,209       464       3,622       464  
TransAct Services Group
    3,766       3,417       10,472       10,926  
Total net sales
  $ 15,358     $ 14,111     $ 48,770     $ 52,324  


 
 

 


TRANSACT TECHNOLOGIES INCORPORATED
 
CONDENSED CONSOLIDATED BALANCE SHEETS
 
(Unaudited)
 
   
September 30,
   
December 31,
 
(In thousands)
 
2012
   
2011
 
Assets:
           
Current assets:
       
 
 
Cash and cash equivalents
  $ 8,577     $ 6,863  
Accounts receivable, net
    9,814       9,583  
Inventories
    10,608       14,151  
Prepaid income taxes
    447       446  
Deferred tax assets
    1,636       1,636  
Other current assets
    750       375  
Total current assets
    31,832       33,054  
                 
Fixed assets, net
    3,207       3,358  
Goodwill
    2,621       2,518  
Deferred tax assets
    882       890  
Intangible assets, net
    2,445       2,861  
Other assets
    114       59  
      9,269       9,686  
Total assets
  $ 41,101     $ 42,740  
                 
Liabilities and Shareholders’ Equity:
               
Current liabilities:
               
Accounts payable
  $ 3,928     $ 3,019  
Accrued liabilities
    3,267       2,672  
Deferred revenue
    183       141  
Total current liabilities
    7,378       5,832  
                 
Deferred revenue, net of current portion
    176       224  
Deferred rent, net of current portion
    322       357  
Accrued contingent consideration
    680       680  
Other liabilities
    317       334  
      1,495       1,595  
Total liabilities
    8,873       7,427  
                 
Shareholders’ equity:
               
Common stock
    109       108  
Additional paid-in capital
    25,780       25,058  
Retained earnings
    23,352       21,613  
Accumulated other comprehensive loss, net of tax
    (55)       (71)  
Treasury stock, at cost
    (16,958)       (11,395)  
Total shareholders’ equity
    32,228       35,313  
Total liabilities and shareholders’ equity
  $ 41,101     $ 42,740